Results 61 to 70 of about 1,053 (167)

UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review [PDF]

open access: yes, 2004
BACKGROUND: Broad-band UVA, long-wave UVA1 and PUVA treatment have been described as an alternative/adjunct therapeutic option in a number of inflammatory and malignant skin diseases.
A Glockenberg   +145 more
core   +2 more sources

Acral papular mucinosis: a new case of this rare entity [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2016
Acral persistent papular mucinosis (APPM) is a rare subtype of localized lichen myxedematosus. It consists of small papules localized exclusively on the back of the hands, wrists and extensor aspects of distal forearms with no other clinical or ...
María Encarnación Gómez Sánchez   +4 more
doaj   +1 more source

Sklerodermie und fibrosierende Erkrankungen [PDF]

open access: yes, 2018
Zusammenfassung: Bei der Sklerodermie und anderen fibrosierenden Erkrankungen wie den Fibromatosen, der Arthrofibrose und dem M.Ormond liegt eine Fibroblastenproliferation mit mehr oder weniger starker Begleitentzündung vor. Bei der Sklerodermie kommt es
Jakobs, M.   +3 more
core  

Cutaneous manifestations of monoclonal gammopathy

open access: yesBlood Cancer Journal, 2022
Monoclonal gammopathy associated with dermatological manifestations are a well-recognized complication. These skin disorders can be associated with infiltration and proliferation of a malignant plasma cells or by a deposition of the monoclonal ...
Jean-Sebastien Claveau   +2 more
doaj   +1 more source

Therapeutic Plasma Exchange for the Symptomatic Treatment of Scleromyxedema: A Case Report and Literature Review

open access: yesJournal of Clinical Apheresis, Volume 39, Issue 6, December 2024.
ABSTRACT Scleromyxedema is a rare skin mucinosis often associated with systemic involvement and monoclonal gammopathy (MG). No formal recommendation for management with therapeutic plasma exchange (TPE) has been published due to rarity. This paper reports a 42‐year‐old male with progressive scleromyxedema.
Matthew H. Lanehart   +2 more
wiley   +1 more source

Escleromixedema associado a miocardiopatia Scleromyxedema with associated cardiomyopathy

open access: yesAnais Brasileiros de Dermatologia, 2004
Relato de um caso de escleromixedema com lesões cutâneas associadas a miopatia, disfunção esofageana e paraproteinemia. Durante a evolução, a paciente apresentou sintomas de insuficiência cardíaca congestiva (ICC) que foram relacionados à miocardiopatia,
Gladys Aires Martins   +2 more
doaj   +1 more source

Adult Variant of Self-healing Cutaneous Mucinosis in a Patient with Epilepsy [PDF]

open access: yes, 2016
A 52-year-old woman was admitted with a 3 weeks history of periorbital edema and lips swelling. She developed several subcutaneous firm erythematous papules and nodules on the face, scalp and two indurated plaques on the upper back and left forearm ...
Aliabdi, Maryam   +5 more
core   +2 more sources

Case report: A novel high‐dose intravenous immunoglobulin preparation for the treatment of severe pemphigus vulgaris failing standard therapy

open access: yesThe Journal of Dermatology, Volume 51, Issue 12, Page 1665-1668, December 2024.
Abstract Pemphigus vulgaris (PV) is a severe autoimmune bullous dermatosis that is characterized by autoantibodies against epidermal adhesion proteins causing painful mucosal and skin blistering. Standard treatments for PV include corticosteroids, steroid‐sparing immunosuppressants, or intravenous monoclonal anti–CD20‐antibody therapy.
Nadine Wiedenmayer   +4 more
wiley   +1 more source

High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease

open access: yesFrontiers in Immunology, 2019
The immunomodulatory potential and low incidence of severe side effects of high-dose intravenous immunoglobulin (IVIg) treatment led to its successful application in a variety of dermatological autoimmune diseases over the last two decades.
Jochen H. O. Hoffmann, Alexander H. Enk
doaj   +1 more source

Biomarkers in skin autoimmunity—An update on localised scleroderma

open access: yesSkin Health and Disease, Volume 4, Issue 2, April 2024.
Newest research on biomarkers in localised scleroderma reviewed. Abstract Human autoimmune diseases are complex and highly diverse conditions that can be of localised or systemic nature. Understanding the basic biology of autoimmune diseases goes hand in hand with providing the clinics with valuable biomarkers for managing these diseases.
Adrián Hernández‐Bustos   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy